TGFB1 and COVID-19: Notably, the post-acute cardiovascular manifestations of COVID-19 were widely reported (Xie et al., 2022) and the putative mechanisms interestingly involved fibrosis and scarring of cardiac tissue caused by activated TGF-β signaling (Mustroph et al., 2021).